Secuelas de salud a medio plazo en brasileños recuperados de COVID-19 según gravedad

Estudio AEROBICOVID

  • Alba Camacho-Cardenosa Department of Physical Education and Sports, University of Granada, Granada, Spain.
  • Javier Brazo-Sayavera Department of Sports and Computer Science, Universidad Pablo de Olavide, Seville, Spain; PDU EFISAL, Centro Universitario Regional Noreste, Universidad de la República, Rivera, Uruguay.
  • Marta Camacho Cardeñosa Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, España
  • Gabriel Peinado-Costa School of Physical Education and Sport of Ribeirao Preto, University of Sao Paulo (USP), Ribeirao Preto, SP, Brazil.
  • Ester Wiggers Ribeirao Preto Medical School, USP, Ribeirão Preto, SP, Brazil.
  • Elisangela Aparecida da Silva-Lizzi Academic Department of Mathematics, Federal University of Technology - Paraná, Cornélio Procópio, PR, Brazil.
  • Pedro Vieira Da Silva-Neto Graduate Program in Basic and Applied Immunology - PPGIBA, Institute of Biological Sciences, Federal University of Amazonas (UFAM), Manaus, AM, Brazil; Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeirao Preto (FCFRP), USP, Ribeirao Preto, SP, Brazil.
  • João Pedro Rodrigues-Campos Renon Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeirao Preto (FCFRP), USP, Ribeirao Preto, SP, Brazil.
  • Carlos Arterio Sorgi Department of Chemistry, Faculty of Philosophy, Sciences and Letters of Ribeirao Preto (FFCLRP), USP, Ribeirao Preto, SP, Brazil.
  • Átila Alexandre Trapé School of Physical Education and Sport of Ribeirao Preto, University of Sao Paulo (USP), Ribeirao Preto, SP, Brazil.
Palabras clave: COVID-19, Seguimiento, Salud, Después del alta

Resumen

The aims were to identify the symptoms and comorbidities predictive for severe illness and analyse the mild-term health sequelae in Brazilian recovered from COVID-19. Eighty-four participants were divided into mild (n = 16), moderate (n = 51), severe (n = 9) or critical (n = 8) gravity. A standardized assessment included: anamnesis to identify the symptoms and comorbidities; and cardiorespiratory system, body composition, haematological and immunological indicators, and physical fitness to analyze the mild-term health sequelae. Participants with higher gravity presented fever, fatigue and dyspnoea. Diabetes (p = 0.003), hypertension (p < 0.001) and metabolic syndrome (p = 0.010) were the comorbidities significantly associated for severe or critical illness. People with critical gravity reported a significant higher waist/hip ratio and level of visceral fat compared with mild and moderate severity. Severe and critical participants reported worst results in agility and balance test compared with mild (p = 0.015; p = < 0.001, respectively) and moderate (p = 0.014; p = < 0.001, respectively) gravity. Fever, fatigue and dyspnoea; and diabetes, hypertension and metabolic syndrome were the symptoms and comorbidities associated with higher gravity. Mild-term, altered values of body composition, physical functioning, enhanced glucose, reticulocytes, and lymphocytes levels were reported.

Publicado
2024-02-28
Sección
Originales